ARMP

Armata Pharmaceuticals Inc

$10.83

+0.2 (+1.88%)

Analyst Overview

Target Price:

Date: 27.02.2026

$15.00

(+38.5%)

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of specific bacteriophage therapies for the treatment of antibiotic-resistant infections worldwide. The company is headquartered in Marina del Rey, California.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

5005 MCCONNELL AVENUE, LOS ANGELES, CA, UNITED STATES, 90066

Fiscal year end:

December

Market capitalization:

$387 Million

EBITDA:

-$31.9 Million

PERatio:

0.0

EPS:

-1.66

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.421

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-98%

How much will you get:

$16

Prices dates:

29-01-2016: $420.00 and 30-01-2026: $6.70